Zynex News

Zynex to Present at the RBC Capital Markets Global Healthcare Conference

ENGLEWOOD, Colo., May 9, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ma

PR NewswireMay 9 09:15 ET

3 Reasons Growth Investors Will Love Zynex (ZYXI)

Yahoo FinanceMay 7 12:45 ET

Zynex Executives Recognized Among Top 25 in Medical Technology

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for...

PR NewswireMay 7 09:15 ET

We Think You Can Look Beyond Zynex's (NASDAQ:ZYXI) Lackluster Earnings

The market for Zynex, Inc.'s (NASDAQ:ZYXI) shares didn't move much after it posted weak earnings recently. Our analysis suggests that while the profits are soft, the foundations of the business are s

Simply Wall StMay 7 08:06 ET

Catalyst Watch: Disney Earnings, Apple iPad Event and Fed Speakers Back on the Circuit

Seeking AlphaMay 3 15:00 ET

Zynex Inc (ZYXI) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and Seizing ...

Yahoo FinanceMay 2 07:01 ET

Zynex, Inc. (NASDAQ:ZYXI) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Investors in Zynex, Inc. (NASDAQ:ZYXI) had a good week, as its shares rose 4.8% to close at US$11.77 following the release of its first-quarter results. It was a curious result overall, with reven

Simply Wall StMay 2 06:05 ET

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Exelixis (EXEL) and Zynex (ZYXI)

TipRanksMay 1 06:42 ET

RBC Capital Reaffirms Their Buy Rating on Zynex (ZYXI)

TipRanksMay 1 06:40 ET

Express News | HC Wainwright & Co. Reiterates Buy on Zynex, Maintains $21 Price Target

BenzingaMay 1 06:33 ET

Zynex Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/01/2024 89.02% HC Wainwright & Co. → $21 Reiterates Buy → Buy 03/01/2024 35.01% RBC Capital $13 → $15 M

BenzingaMay 1 06:32 ET

Maintaining Buy Rating for Zynex on Strong Growth and Positive Outlook

TipRanksMay 1 06:18 ET

Earnings Call Summary | Zynex(ZYXI.US) Q1 2024 Earnings Conference

The following is a summary of the Zynex, Inc. (ZYXI) Q1 2024 Earnings Call Transcript:Financial Performance:Zynex reported a 10% increase in Q1 2024 revenue year-over-year, despite slight disruptions

moomoo AIMay 1 05:36 ET · Conference Call

Zynex Inc (ZYXI) Q1 2024 Earnings: Revenue Meets Expectations, EPS Falls Short

Yahoo FinanceApr 30 17:44 ET

Express News | Zynex Reaffirms 2024 Revenue Guidance Of At Least $227M

BenzingaApr 30 17:04 ET

Express News | Zynex Inc FY2024 Shr View $0.48, Rev View $227.4 Mln -- Lseg Ibes Data

ReutersApr 30 16:09 ET

Express News | Zynex Inc Q2 Shr View $0.07, Rev View $53.1 Mln -- Lseg Ibes Data

ReutersApr 30 16:09 ET

Express News | Zynex Inc: Sees Q2 Diluted EPS to Be at Least $0.08.

ReutersApr 30 16:09 ET

Express News | Zynex Inc: Sees Q2 2024 Revenue Is Estimated to Be at Least $52.0 Mln

ReutersApr 30 16:08 ET

Express News | Zynex Inc: Expects Revenue for Full Year to Remain as Originally Forecasted

ReutersApr 30 16:08 ET